IL1B and COVID-19: The coronavirus disease 2019 (COVID-19) is associated with cytokine dysregulation, increased IL-1β, tumor necrosis factor (TNF) and IL-6 release with hyperinflammation and risk of CSS (Figure 1) [10,11,12,13,14].